Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04HQC
|
|||
| Former ID |
DIB001078
|
|||
| Drug Name |
SB-9200
|
|||
| Synonyms |
SB 9200
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2 | [1] | |
| Company |
Spring bank pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H34N7O13PS
|
|||
| Canonical SMILES |
CC(C)OC(=O)OCSP(=O)(OCC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)O)OC4C(OC(C4OC)N5C=CC(=O)NC5=O)CO
|
|||
| InChI |
1S/C25H34N7O13PS/c1-12(2)42-25(37)40-11-47-46(38,45-19-14(7-33)44-23(20(19)39-3)31-5-4-16(35)30-24(31)36)41-8-15-13(34)6-17(43-15)32-10-29-18-21(26)27-9-28-22(18)32/h4-5,9-10,12-15,17,19-20,23,33-34H,6-8,11H2,1-3H3,(H2,26,27,28)(H,30,35,36)/t13-,14+,15+,17+,19+,20+,23+,46?/m0/s1
|
|||
| InChIKey |
CJCYTUJOSMYXLE-JDLSZIHUSA-N
|
|||
| CAS Number |
CAS 942123-43-5
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02751996) A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV (ACHIEVE). U.S. National Institutes of Health. | |||
| REF 2 | Company reprot (Spring Bank Pharmaceuticals) (drug: SB 9200) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.